SCHEMBL26040751

SCHEMBL26040751

Cc1cc(N)c(OC(C)C)cc1C1CCN(C(=O)OC(C)(C)C)CC1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.38
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
GPR119 Q8TDV5 7/20 0.37
USP30 Q70CQ3 3/20 0.37
PDE4B Q07343 1/20 0.37
MAPT P10636 2/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KDM4E B2RXH2 1/20 0.36
THRB P10828 1/20 0.36
PIK3CA P42336 1/20 0.36
SMARCA2 P51531 1/20 0.35
SMARCA4 P51532 1/20 0.35
PBRM1 Q86U86 1/20 0.35
MDM2 Q00987 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17304017 0.88 PDE4B (0.44) DPP4HDAC1HDAC2GPR119PDE4B
SCHEMBL1012726 0.85 MAPT (0.46) DPP4GPR119PDE4BMAPTNPC1
SCHEMBL17304222 0.85 SCN9A (0.42) DPP4USP30PDE4BMAPTALDH1A1
SCHEMBL17303726 0.83 KDM4E (0.38) DPP4HDAC1HDAC2PDE4BMAPT
SCHEMBL17879568 0.80 DPP4 (0.35) DPP4GPR119MAPTNPC1ALDH1A1
SCHEMBL17304050 0.79 MAPT (0.47) DPP4GPR119PDE4BMAPTNPC1
SCHEMBL17303760 0.77 PDE4B (0.46) GPR119PDE4BPIK3CA
SCHEMBL28007082 0.75 DPP4 (0.45) DPP4GPR119PDE4BMAPTNPC1
SCHEMBL17304130 0.74 PDE4B (0.54) GPR119PDE4BMAPTKDM4ETHRB
SCHEMBL17304040 0.74 MAPT (0.43) DPP4GPR119PDE4BMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3150592-B1 ALK KINASE INHIBITOR, AND PREPARATION METHOD AND USE THEREOF SHANGHAI EMERALD WELLCARES PHARMACEUTICAL CO LTD (CN) 2023-08-30 EP disclosed